Table 1. MDR Enterobacterales and Pseudomonas aeruginosa included in the study.
MDROs: multidrug-resistant organisms; CRO: carbapenem-resistant organisms; CSO: carbapenem-susceptible organisms.
*Others, includes Providencia (1), Citrobacter braakii (1), and Proteus mirabilis (3).
MDROs | CRO (% (n/N)) (N = 283) | CSO (% (n/N)) (N = 41) | Total (% (n/N)) (N = 324) |
Enterobacterales | 89.4 % (253/283) | 97.6 % (40/41) | 90.4% (293/324) |
Escherichia coli | 22.3 % (63/283) | 58.5% (24/41) | 26.9 % (87/324) |
Klebsiella pneumoniae | 61.1 % (173/283) | 29.3 % (12/41) | 57.1 % (185/324) |
Enterobacter cloacae | 4.2% (12/283) | 9.8% (4/41) | 4.9% (16/324) |
Others* | 1.8 % (5/283) | 0 (0/41) | 1.5 % (5/324) |
Pseudomonas aeruginosa | 10.6% (30/283) | 2.4 % (1/41) | 9.6 % (31/324) |